hayfever

Patients

When it comes to hayfever, proactive approach improves patient health literacy and empowers individuals to put their health back in their own hands.

News

AstraZeneca has staked a claim to the increasingly crowded IgAN market with an accelerated approval from the FDA for Ultomiris, its fifth indication.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.